Consistent with these data, examination of RNAseq data from the independent TCGA EC series confirmed significant enrichment for immune-related pathways and a highly specific 200-gene tumor T cell infiltration signature in POLE proofreading-mutant ECs. The gene discussed is POLE; the disease is neoplasm.